Temporary percutaneous cardiac support devices are reviewed regarding the scientific principles that govern their hemodynamic effectiveness and myocardial protection in various clinical situations.
This review outlines the scientific principles of hemodynamic effectiveness and myocardial protection for percutaneous cardiac support devices across various acute cardiovascular conditions.
Patients in a variety of cardiovascular disease states may benefit from temporary percutaneous cardiac support, including those in acute decompensated heart failure, fulminant myocarditis, acute myocardial infarction with or without cardiogenic shock and those undergoing high-risk percutaneous coronary intervention. The ideal percutaneous cardiac support device is safe, easy to use and versatile enough to meet the needs of various clinical situations and patient cohorts. In addition, it should provide maximal hemodynamic support and protection against myocardial ischemia. With these goals in mind, the scientific principles that govern hemodynamic effectiveness and myocardial protection as they pertain to acute support devices are reviewed.
Burkhoff et al. (Mon,) conducted a review in Cardiovascular disease states requiring temporary percutaneous cardiac support. Percutaneous hemodynamic support devices was evaluated. Temporary percutaneous cardiac support devices are reviewed regarding the scientific principles that govern their hemodynamic effectiveness and myocardial protection in various clinical situations.